<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02068391</url>
  </required_header>
  <id_info>
    <org_study_id>RISE2-2014-312185</org_study_id>
    <nct_id>NCT02068391</nct_id>
  </id_info>
  <brief_title>Recovery Improved in Covert Stroke With Exercise</brief_title>
  <acronym>RISE-2</acronym>
  <official_title>Achieving Brain Benefits in Covert Stroke Through Aerobic Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Toronto Rehabilitation Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Silent ischemic, also known as &quot;covert stroke vascular disease&quot; (CSVD), contributes to
      neurological deficits that are caused by damage to small blood vessels in the brain. CSVD
      occurs six to ten times more often that an acute stroke. It is misleading to think, however,
      that CSVD is an inevitable part of &quot;getting old&quot; because people with CSVD are at high risk of
      developing an acute stroke or dementia. In fact, people with more CSVD lesion volume are more
      likely to develop day to day problems in planning, decision-making and speed of thinking.
      Unfortunately, there are no proven therapies designed to address CSVD. We propose to test
      whether aerobic exercise is an intervention that can combat CSVD because the disease is
      fundamentally a blood flow problem that may be improved by aerobic exercise. We will recruit
      CSVD adults with moderate to severe lesion burden and use magnetic resonance imaging (MRI) to
      study the brain in terms of structure, perfusion and function. Participants will be randomly
      assigned to either our established aerobic exercise program or a control stretching program.
      Both groups will take part in lab exercise sessions, which are designed to monitor progress
      and assess adherence to the program. The duration and intensity of their exercise will
      increase as participants progress. We will use activity log books, phone calls and extra
      &quot;booster&quot; exercise sessions, as needed, to maximize retention and adherence. We aim to show
      that aerobic exercise increases cerebral blood flow (CBF) in frontal-subcortical grey matter,
      supports regional tissue growth, and improves cognitive function in CSVD adults with
      substantial risk of acute stroke and dementia. A positive outcome of this research will
      provide strong support for additional clinical trials aimed at sustaining cognition and
      maintaining independent living.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cerebral blood flow from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Pseudo-continuous arterial spin labeling MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in brain structure from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Cortical and subcortical grey matter density using structural MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in brain activity related to attention and executive control tasks from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Blood oxygenation level dependent MRI</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in white matter integrity from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Diffusion tensor imaging (DTI) MRI</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in aerobic fitness from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Peak oxygen uptake</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in aerobic fitness from 6 to 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Peak oxygen uptake</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in autonomic function from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Heart rate variability</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in autonomic function from 6 to 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Heart rate variability</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in arterial stiffness from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Carotid-femoral pulse wave velocity</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in arterial stiffness from 6 to 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Carotid-femoral pulse wave velocity</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in executive function from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Trail Making Test</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in executive function from 6 to 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Trail Making Test</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in balance from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Spatial-temporal synchronization of center of pressure</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in balance from 6 to 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Spatial-temporal synchronization of center of pressure</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in dual task gait from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Comparison of normal gait to gait with verbal math challenge</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in dual task gait from 6 to 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Comparison of normal gait to gait with verbal math challenge</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in grip strength from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>Maximum grip strength with dynamometer</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in grip strength from 6 to 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Maximum grip strength with dynamometer</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cerebral Small Vessel Diseases</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will perform the 'Exercise Program' for months 0 to 6, and will be unsupervised for months 7 to 12.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stretching</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will perform the 'Stretching Program' for months 0 to 6, and the 'Exercise Program' for months 7 to 12.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stretching Program</intervention_name>
    <description>The 'Stretching Program' will teach stretching for the upper and lower limbs, and the trunk, as well as breathing exercises for relaxation. Supervised group activities will be performed once per week (45 minutes) and self-directed stretching will be encouraged 4 days per week and monitored by an activity journal. The intensity of stretching and number of stretches will be progressed every 2 weeks. Heart rate and perceived exertion will be monitored. The program will last 6 months.</description>
    <arm_group_label>Stretching</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Program</intervention_name>
    <description>The 'Exercise Program' will prescribe specific aerobic exercise to the participants. Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise will be encouraged 4 days per week and monitored by an activity journal. The initial walking prescription will be set at ~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% of peak oxygen uptake. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of peak oxygen uptake and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.</description>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_label>Stretching</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Covert stroke: white matter hyperintensities of presumed vascular origin

          -  Ability to walk for 10 minutes without assistance from another person

          -  Fluent in English

          -  Ability to consent

        Exclusion Criteria:

          -  Highly fit individuals exercising â‰¥ 150 minutes per week

          -  Dementia

          -  Multiple Sclerosis

          -  Disabling stroke (ischemic or hemorrhagic)

          -  Major concurrent illness (e.g. chronic obstructive lung disorder, current or
             metastatic cancer, chronic kidney disease)

          -  Major psychiatric illness (e.g. bipolar, schizophrenia, major depression)

          -  Contraindications to MRI scanning (e.g. claustrophobia, implants, prostheses, metallic
             fragments)

          -  Contraindications to exercise (participants must have medical clearance to exercise
             from their attending physician)

          -  Recent change in health status (e.g. hospitalization within past month)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradley MacIntosh, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Robertson, PhD</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>85406</phone_ext>
    <email>adrobert@sri.utoronto.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bradley MacIntosh, PhD</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>7277</phone_ext>
    <email>bmac@sri.utoronto.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2014</study_first_submitted>
  <study_first_submitted_qc>February 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2014</study_first_posted>
  <last_update_submitted>June 16, 2017</last_update_submitted>
  <last_update_submitted_qc>June 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnybrook Health Sciences Centre</investigator_affiliation>
    <investigator_full_name>Dr. Bradley MacIntosh</investigator_full_name>
    <investigator_title>Imaging Scientist</investigator_title>
  </responsible_party>
  <keyword>covert stroke</keyword>
  <keyword>cerebral blood flow</keyword>
  <keyword>grey matter</keyword>
  <keyword>attention</keyword>
  <keyword>executive function</keyword>
  <keyword>aerobic exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Small Vessel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

